North Fulton Therapeutics is categorized under Administration of Social and Human Resources in Atlanta, GA .
North Fulton Therapeutics was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Administration of Social and Human Resources business, which does work in the BOTH market, and is classified as a Administration of Social and Human Resources, under code number 9211200 by the NAICS.
If you are seeking more information, feel free to contact Thomas Hughes at the company’s single location by writing to 6005 Glenridge Drive, Atlanta, Georgia GA 30328 or by phoning (404) 303-6181. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | North Fulton Therapeutics |
Contact Person: | Thomas Hughes |
Address: | 6005 Glenridge Drive, Atlanta, Georgia 30328 |
Phone Number: | (404) 303-6181 |
Website Address: | fultoncountyga.gov |
Annual Revenue (USD): | Unknown |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Administration of Social and Human Resources |
SIC Code: | 9441 |
NAICS Code: | 9211200 |
Share This Business: |
North Fulton Therapeutics was started in 0 to provide professional Administration of Social and Human Resources under the SIC code 9441 and NAICS code 9211200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Thomas Hughes for inquiries that concern North Fulton Therapeutics by calling the company number (404) 303-6181, as your correspondence is most welcome. Additionally, the physical location of the single location of North Fulton Therapeutics can be found at the coordinates 33.91798,-84.36328 as well as the street address 6005 Glenridge Drive in Atlanta, Georgia 30328.
For its online presence, you may visit North Fulton Therapeutics’s website at fultoncountyga.gov and engage with its social media outlets through on Twitter and on Facebook.